Soiken Holdings Inc. engages in the development of biomarkers in Japan. The company is involved in the development and sale of cosmetics and dietary supplements; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. It also provides clinical evaluation tests for foodstuffs using biomarker technology; support for physician-led pharmaceutical clinical research, health checkups, and specific health guidance; and services to health insurance societies, including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes. Soiken Holdings Inc. was incorporated in 1994 and is headquartered in Toyonaka, Japan.

Soiken Holdings Inc.

総医研ホールディングス is involved in commercializing research results in medical science to contribute to people's health and safety in living.

Metric
Company Name	Soiken Holdings Inc.
Symbol	2.38K
MSH ID	COM:SOIKEN
Market	STOCKS
Sector	Healthcare
Industry	Biotechnology
Country	JP
Stage
Employee Count	98
Website	soiken.com
LinkedIn
Founders

Metric
Market Cap	29.15M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	34.40M
Revenue (LTM)
Revenue (NTM)
Gross Profit	16.56M
EBITDA	-3.89M
Operating Income	-4.07M
Net Income	-4.42M
EPS	-0.17
Diluted EPS	-0.17
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.48
Operating Profit Margin	-0.01
EBITDA Margin	-0.11
Net Profit Margin	-0.04
Return on Equity	-0.04
Return on Assets	-0.03
Return on Capital Employed	-0.01

2385

COM:SOIKEN

総医研ホールディングス

Last Close

138.00

25/11 06:45

Market Cap

4.37B

Beta: -

Volume Today

13.90K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-48.79
P/B Ratio	0.69
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.84
EV Multiple	-12.86

Metric
Days Sales Outstanding	19.53
Days Payables Outstanding	15.28
Days Inventory Outstanding	152.88
Operating Cycle	183.22
Cash Conversion Cycle	155.03
Asset Turnover	0.94

Metric
Operating Cash Flow	-5.87M
Free Cash Flow	-5.97M
Cash Flow to Debt	27.71
Operating Cash Flow/Sales	0.01
Free Cash Flow Yield

Metric
Cash & Equivalents	31.95M
Accounts Receivable	-267.92K
Inventory	7.48M
Goodwill
Debt to Capitalization	0.00
Debt to Assets
Current Ratio	8.13
Quick Ratio	8.97

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue